A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD22 for Relapsed/Refractory Leukemia or Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Leukemia
Related studies linked through entity extraction aliases.
A Phase I Trial of Donor- Derived 19-28z CAR T Cells Following Allogeneic Transplant for the Treatment of CD19 Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy for Breast Cancer, Lymphoma or Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Evaluate the Efficacy and Safety of the Prophylactic Use of PEG-rhG-CSF in Children With Hematological Malignancies
- Status
- UNKNOWN
- Phase
- NA
Effect of the Cycloergometer in Patients Undergoing Hematopoietic Stem Cell Transplantation
- Status
- UNKNOWN
- Phase
- NA
Quality Improvement Project - "My Logbook! - I Know my Way Around!"; ("Mein Logbuch - Ich Kenne Mich Aus!")
- Status
- COMPLETED
- Phase
- NA
Healthy Bones, Healthy Life: Habitual Physical Activity on Bone & Metabolic Health in Pediatric Cancer Survivors
- Status
- COMPLETED
- Phase
- N/A
Better Leukemia Diagnostics Through AI (BELUGA)
- Status
- RECRUITING
- Phase
- N/A
Effects of Periodized and Autoregulated Resistance Training in Haematological Cancer Patients During the Treatent.
- Status
- UNKNOWN
- Phase
- NA
Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 Study
- Status
- RECRUITING
- Phase
- N/A
Efficacy and Safety Evaluation of IM19 CAR-T Cell Therapy for MRD+ After Transplantation
- Status
- UNKNOWN
- Phase
- NA
Natural Killer Cell (CYNK-001) Infusions in Adults with AML
- Status
- TERMINATED
- Phase
- PHASE1
Safety and Efficacy of CD123-Targeted CAR-T Therapy for Relapsed/Refractory Acute Myeloid Leukemia
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Safety and Efficacy of CD19-Targeted CAR-T Therapy for Relapsed/Refractory CD19+ B Cell Leukemia and Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
CD19+Targeted CAR-T Cell Therapy for Relapsed/Refractory CD19+ B Cell Leukemia and Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
CD123-Targeted CAR-T Cell Therapy for Relapsed/Refractory Acute Myeloid Leukemia
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Resiliency in Older Adults Undergoing Bone Marrow Transplant
- Status
- COMPLETED
- Phase
- N/A
Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever
- Status
- COMPLETED
- Phase
- PHASE4